Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT04977466
Other study ID # 10000268
Secondary ID 000268-CC
Status Enrolling by invitation
Phase
First received
Last updated
Start date June 5, 2023
Est. completion date December 30, 2045

Study information

Verified date October 24, 2023
Source National Institutes of Health Clinical Center (CC)
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Background: In 2018, the NIH intramural research program had almost 23,000 people taking part in active clinical research studies. Half of those people were female. More than a third were of child-bearing age. Researchers want to use data from this group to create a pregnancy registry. It will be used to collect data about pregnancy and birth outcomes related to unplanned exposure to research products. These products may include drugs, vaccines, treatments, and interventions. Objective: To collect data about pregnancies and births from people who took part in an NIH clinical trial and their partners who became pregnant while in the study or shortly after. Eligibility: People of any age and their partners who took part in an NIH clinical trial and became pregnant while in the study or within 1 year after. Design: Participants will be screened by phone. Their clinical trial history will be verified. Participants will be interviewed in person, by phone, or virtually. They will be asked about their health and their trial experience in relation to their pregnancy. They will give details about their pregnancy and baby (if appliable). They will be interviewed every 6 months for 1 year after the birth of their baby, as applicable. Data from both NIH and outside medical records will be used. Participants will give their doctor s name and contact details. They will provide a release for their records to be used. If needed, they will provide a release for their baby s records. Data will be coded and stored in a database on an in-house NIH secure server. Data may be used in future studies


Description:

Study Description: This protocol will serve as a pregnancy registry to collect prospective and retrospective health information from current and former NIH intramural research participants, their partners and offspring that became pregnant during or within 1 year after participating in an NIH intramural clinical trials. The registry will provide supplemental data on outcomes of clinical trial interventions on pregnancy and delivery of offspring as this information is seldom available because pregnant women are often immediately excluded from study participation upon becoming pregnant and data from women who became pregnant and their offspring outcomes is not systematically or routinely collected and evaluated in the intramural program at the NIH. Partners of women who became pregnant within 1 year following research study participation in clinical trials will be invited to participate to evaluate if participation in clinical trials extends to those in close contact. Objective: To collect information about pregnancy and offspring outcomes from NIH intramural clinical trial participants and/or partners of current and former NIH research participants. Study Population: Adult participants: Females that participated in NIH intramural clinical trials and became pregnant while on study or within 1 year after. Male or female partners of women that participated in NIH intramural clinical trials that became pregnant while they were on study or within 1 year after. Female partners of NIH intramural clinical trials participants that became pregnant while their partner was or within 1 year after their partner was on a study. Offspring from birth to 12 months of age and born to: Females that participated in NIH intramural clinical trials and became pregnant while on study or within 1 year after. Male or female partners of women that participated in NIH intramural clinical trials that became pregnant while they were on study or within 1 year after. Female partners of NIH intramural clinical trials participants that became pregnant while their partner was or within 1 year after their partner was on a study.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 500
Est. completion date December 30, 2045
Est. primary completion date December 30, 2045
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 1 Day to 100 Years
Eligibility - INCLUSION CRITERIA: In order to be eligible to participate in this study, an individual must meet all of the following criteria: - All Participants - Able and willing to provide written informed consent for study participation. - Stated willingness to comply with all data collection study activities - Male or female, aged 0-100 years - Participant or partner of a participant on NIH protocol - Group #1 (Pregnant Female NIH Participants) Female NIH study participants with a confirmed pregnancy that occurred during or within 1 year after the last day of intervention during participation in NIH intramural clinical trials AND that meet at least one of the following criteria/assessments: - Positive pregnancy test (serum or urine) - Auscultation of fetal heart tones - Clinical assessment of fetal movement - Demonstration of pregnancy by ultrasound - Group #2 (Male and Female Partners) Male or female partners of women who participated in NIH intramural clinical trials and that became pregnant while they were on study or within 1 year of the last day of intervention. -Group #3 (Pregnant Female Partners of Male or Female NIH Clinical Trial Participants) Female partners of NIH intramural clinical trial participants who became pregnant while their partner was or within 1 year after the last day of intervention after their partner was on a study AND who meet at least one of the following criteria/assessments: - Positive pregnancy test (serum or urine) - Auscultation of fetal heart tones - Clinical assessment of fetal movement - Demonstration of pregnancy by ultrasound - Group #4 (Neonate or Offspring of a Pregnant Female Participant or Pregnant Female Partner) Offspring from birth to 12 months of age and born to: - Females who participated in an NIH intramural clinical trial and became pregnant while on study or within 1 year after. - Female partners of women or men who participated in an NIH intramural clinical trial who became pregnant while they were on study or within 1 year after. EXCLUSION CRITERIA: An individual who meets any of the following criteria will be excluded from participation in this study: - Participation in NIH research studies that do not meet criteria of a clinical trial, such as natural history or observational studies - Pregnancy that occurs/occurred more than 1 year after NIH clinical trial participation

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States National Institutes of Health Clinical Center Bethesda Maryland

Sponsors (1)

Lead Sponsor Collaborator
National Institutes of Health Clinical Center (CC)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Enrollment of the last study subject The only outcome of the study is to enroll all study stubjects. End of study
See also
  Status Clinical Trial Phase
Recruiting NCT06313112 - Impact of Food Insecurity on Utilization of Maternal Healthcare Services and Birth Outcomes in Slums in Pune, India
Recruiting NCT03242746 - Cervical Morphological Changes on Pregnancy Outcome
Recruiting NCT04515134 - Assessment of Follicular Fluid Level of Coenzyme Q10 in Women Undergoing ICSI
Completed NCT03740568 - Effect of Intervention on Progesterone Levels Before Euploid Embryo Transfer in Pregnancy Outcomes. N/A
Completed NCT05355038 - Effect of Lifestyle Modification on Pregnancy Outcome for GDM N/A
Recruiting NCT05506631 - Foley Balloon Study for Cervical Ripening - Cost Comparison Between Outpatient and Inpatient Cervical Ripening N/A
Terminated NCT03489174 - Routine Pregnancy Screening for Women on Opioid Substitution Therapy N/A
Completed NCT03748576 - A Prospective Randomized Controlled Trial of Mobile Medical Used for Management of Pregnant Women N/A
Active, not recruiting NCT03113331 - The 3D Cohort Study (Design, Develop, Discover)
Active, not recruiting NCT03215368 - The Ma'Anshan Birth Cohort (MABC)
Recruiting NCT04930276 - Diet-glucose-gut Microbiome Net in Women With GDM N/A
Withdrawn NCT05847140 - A Non-interventional Multi-country Cohort Study to Assess the Safety of EVUSHELD™ During Pregnancy
Active, not recruiting NCT02271490 - Acrosome Reaction Induction Prior to ICSI N/A
Not yet recruiting NCT04434547 - A RCT on the Effect of Platelets Rich Plasma in ICSI Patients With Recurrent Implantation Failure Phase 2
Not yet recruiting NCT04434495 - Outcome of Platelet Rich Plasma in ICSI Patients, a Randomized Controlled Trial Phase 2
Completed NCT05647538 - Bilateral Uterine Artery Ligation After Intrapartum or Postpartum Hemorrhage on Ovarian Reserve Markers and Pregnancy Outcome
Completed NCT00878098 - Study of DDT and Loss of Clinically-Recognized Pregnancies in South Africa
Completed NCT01653392 - BioThrax® (Anthrax) Vaccine in Pregnancy Registry
Recruiting NCT05733377 - Non-invasive Imaging Technique for the Study of Lordosis in Pregnant Women and Its Relationship to Birth Outcome
Not yet recruiting NCT05457335 - 2.Comparison of the Live Birth Rate of PGT Versus Expectant Management in Patients With RPL